Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-23

FDA Approved: LOXAPINE — Supplemental Application (Elite Laboratories, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for LOXAPINE submitted by Elite Laboratories, Inc., for this generic loxapine product. Loxapine is an antipsychotic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOXAPINE (loxapine)

Snippet

SUPPL AP for LOXAPINE (LOXAPINE)